P. A. Callejas

发表

Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

R. Hermida, J. Fernandez, A. Moyá, 2020, Chronobiology International.

The Hygia Project and Hygia Chronotherapy Trial: insights of we clinical investigators on the impact of the embedded continuing medical education on primary-care practice and improved patient cardiovascular health

A. Moyá, J. J. Crespo, M. T. Ríos, 2020, Chronobiology international.

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.

R. Hermida, D. Ayala, J. Fernandez, 2019, European heart journal.

Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk.

R. Hermida, D. Ayala, J. Fernandez, 2018, European heart journal.

Effects of Time-of-Day of Hypertension Treatment on Ambulatory Blood Pressure and Clinical Characteristics of Patients With Type 2 Diabetes

R. Hermida, D. Ayala, A. Moyá, 2013, Chronobiology international.

Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention

R. Hermida, D. Ayala, A. Moyá, 2018, European heart journal.

Prevalence and Clinical Characteristics of Isolated-Office and True Resistant Hypertension Determined by Ambulatory Blood Pressure Monitoring

R. Hermida, D. Ayala, M. T. Ríos, 2013, Chronobiology international.

Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure.

M. Smolensky, R. Hermida, D. Ayala, 2020, Revista espanola de cardiologia.